Karin Heidemann
Directeur Technique/Scientifique/R&D chez CHAMPIONS ONCOLOGY, INC.
Postes actifs de Karin Heidemann
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHAMPIONS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/09/2019 | - |
Historique de carrière de Karin Heidemann
Anciens postes connus de Karin Heidemann
Sociétés | Poste | Début | Fin |
---|---|---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Corporate Officer/Principal | 01/03/2017 | 01/09/2019 |
Formation de Karin Heidemann
Universität zu Köln | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Allemagne | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHAMPIONS ONCOLOGY, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Health Technology |
- Bourse
- Insiders
- Karin Heidemann
- Expérience